A leading researcher and analyst of surgical resident training will deliver the annual Richard Schwartz Memorial lecture at the W.T. Young Library Auditorium on Thursday evening, November 10.
Gary Dunnington, the Jay L. Grossfeld Professor and Chair of Surgery at Indiana University School of Medicine, has been an author and contributor to numerous publications regarding operative performance assessments of surgeons during general residency and fellowship training.

University of Kentucky Markey Cancer Center Oncologist Dr. Edward Romond spent his career at UK treating and studying breast cancer, even leading major Phase 3 clinical trials on the breast cancer drug trastuzumab in the early 2000s. Commonly known as Herceptin, this drug became a standard of care for patients with HER2-positive breast cancer.

Though he retired from practice last year, Romond continues to work part-time with the research team at Markey, this time pushing toward a cure for a different, more deadly, type of breast cancer. 

When we think of research, our minds may possibly conjure up an image of a scientist in a white coat, hunched over a lab table, pouring chemicals into beakers. But research takes a multitude of forms, and flourishes in many different fields. From clinical trials for new cancer medication, to composing and recording an album of original music, and even to studying and refining the most effective ways to cure a country ham. Research often leads us toward answering questions we didn’t even think to ask. 

The University of Kentucky Center for Clinical and Translational Science (CCTS) announced today that it received a four-year, $19.8 million Clinical and Translational Science Award (CTSA) from the National Center for Advancing Clinical and Translational Sciences at the National Institutes of Health. CTSA grants support innovative solutions to improve the efficiency, quality, and impact of translating scientific discoveries into interventions or